 |
| Severe Acute
Respiratory Syndrome (SARS) |
Public
Health Guidance for Community-Level Preparedness and Response
to Severe Acute Respiratory Syndrome (SARS) Version
2 (Jan 8, 2004)
This is an updated version of the draft guidance document issued
by CDC in November 2003. CDC revised the draft based on comments received
from public health partners, healthcare providers, and others. CDC
will continue to update the document as necessary to incorporate additional
comments and to reflect increased understanding of SARS-CoV transmission
dynamics and the availability of improved prevention tools.
In
the Absence of SARS-CoV Transmission Worldwide: Guidance for
Surveillance, Clinical and Laboratory Evaluation, and Reporting Version
2 (Jan
21, 2004)
This is an updated version of a document first issued by CDC in December
2003. The document provides guidance for surveillance, clinical and
laboratory evaluation, and reporting in the setting of no known person-to-person
transmission of SARS-CoV worldwide. Recommendations are derived from Public
Health Guidance for Community-Level Preparedness and Response to Severe
Acute Respiratory Syndrome (SARS). If person-to-person transmission of
SARS-CoV recurs anywhere in the world, CDC will promptly review all
available information and provide additional guidance via the Health Alert
Network (HAN), Epi-X, and partner organizations. Current information will
also be posted on this website.
Clinical
Guidance on the Identification and Evaluation of Possible SARS-CoV
Disease among Persons Presenting with Community-Acquired Illness Version
2
(Jan 8, 2004)
This is an updated version of a document first issued by CDC in
December 2003. This document provides guidance on the clinical
evaluation and management of patients who present from the community with
fever and/or respiratory illnesses. The material in this document supplements
the information provided in Public Health
Guidance for Community-Level Preparedness and Response to Severe Acute
Respiratory Syndrome (SARS).
|
|
|
